Webinar: Adult Epilepsy: Common Clinical Issues and New Therapies

Mon, Nov 2, 2015
1:00pm to 2:00pm ET

Description

A webinar featuring Mayo Clinic neurologists Jeffrey Britton, M.D., Gregory Cascino, M.D., Jerry Shih, M.D., and Joseph Sirven, M.D.. The physicians discuss a variety of adult epilepsy topics including:

  • Seizure medications: when to start and when can they be stopped.
  • Maximizing safety for patients with epilepsy.
  • Indications for admission to epilepsy monitoring unit.
  • New surgical therapies such as laser thermoablation.

Would you like to:

Learn more about Epilepsy

Schedule your appointment

Location

Online

Can we get some info on catamenial epilepsy? Or seizures that seem to be leaning towards drug-resistant?

REPLY

What is your opinion on Charlottes Web oil?

REPLY

can you talk about the effects of seizures on the brain. i.e. do they damage the brain. Do seizures increase the occurrence of seizures. Do uncontrolled seizures increase the risk of SUDEP?

REPLY

Have you used Charlottes Web oil? I hear a lot of good about it for some. Others (like my daughter) would probably need the whole indica plant oil. Living in a state that does not allow it is very hard.

REPLY

conversations with doctors go no where anymore.

REPLY

How does a patient get an appointment/consultation with Mayo neurologists/neuroendocrinologists at the same time? What is required?

REPLY

Are there any particular supplements or over the counter medicines that have been shown to be more active at causing seizures?

REPLY

Why does fever or illness lower the threshold of seizures?

REPLY

When considering persons who do not have epilepsy, what are precautions for them to take from having a seizures in their lifetime? I have been cured for over 24 years and like to have family/friends to take precautions.

REPLY

Does epilipsey/seizures cause memory loss/ recall or is it more likely to be caused by medication? I take Depakote and have been on it for about 27 years.

REPLY
Please sign in or register to post a reply.